| Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma PP Provenzano, C Cuevas, AE Chang, VK Goel, DD Von Hoff, ... Cancer cell 21 (3), 418-429, 2012 | 2256 | 2012 |
| RUNX3 controls a metastatic switch in pancreatic ductal adenocarcinoma MC Whittle, K Izeradjene, PG Rani, L Feng, MA Carlson, KE DelGiorno, ... Cell 161 (6), 1345-1360, 2015 | 218 | 2015 |
| Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells H Lu, Y Yang, E Gad, CA Wenner, A Chang, ER Larson, Y Dang, ... Clinical Cancer Research 17 (1), 67-76, 2011 | 168 | 2011 |
| Pulsed high-intensity focused ultrasound enhances delivery of doxorubicin in a preclinical model of pancreatic cancer T Li, YN Wang, TD Khokhlova, S D'Andrea, F Starr, H Chen, JS McCune, ... Cancer research 75 (18), 3738-3746, 2015 | 103 | 2015 |
| Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade H Lu, WM Wagner, E Gad, Y Yang, H Duan, LM Amon, N Van Denend, ... The Journal of Immunology 184 (9), 5360-5367, 2010 | 95 | 2010 |
| Hyperthermia-enhanced targeted drug delivery using magnetic resonance-guided focussed ultrasound: a pre-clinical study in a genetic model of pancreatic cancer N Farr, YN Wang, S D’Andrea, F Starr, A Partanen, KM Gravelle, ... International Journal of Hyperthermia 34 (3), 284-291, 2018 | 50 | 2018 |
| Analysis of clinical prognostic factors for adult patients with head and neck sarcomas AE Chang, X Chai, SM Pollack, E Loggers, E Rodler, J Dillon, ... Otolaryngology–Head and Neck Surgery 151 (6), 976-983, 2014 | 28 | 2014 |
| Phase I/II trial of combined pegylated liposomal doxorubicin and cyclophosphamide in metastatic breast cancer AE Chang, QV Wu, IC Jenkins, JM Specht, VK Gadi, JR Gralow, ... Clinical breast cancer 18 (1), e143-e149, 2018 | 27 | 2018 |
| Multiple liver abscess formation and primary gastrointestinal stromal tumor AE Chang, GN Mann, B Hoch, ET Loggers, SM Pollack, O Kolokythas, ... Rare tumors 5 (3), 167-168, 2013 | 4 | 2013 |
| Phase I/IB multicenter study of afatinib in combination with capecitabine in patients (pts) with refractory solid tumors and pancreatico-biliary cancers. AE Chang, S Shahda, WP Harris, S Cohen, AL Coveler, BH O'Neil, ... Journal of Clinical Oncology 35 (4_suppl), TPS515-TPS515, 2017 | 2 | 2017 |
| Homologous recombination deficiency (HRD) by BROCA-HR and survival outcomes after surgery for patients (pts) with pancreatic adenocarcinoma (PC): A single institution experience. AE Chang, DB Zhen, M Radke, KK Baker, AL Coveler, KM Wong, ... Journal of Clinical Oncology, 2020 | 1 | 2020 |
| Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic Cancer (vol 75, pg 3738, 2015) T Li, YN Wang, TD Khokhlova, S D'Andrea, F Starr, H Chen, JS McCune, ... CANCER RESEARCH 77 (10), 2771-2771, 2017 | 1 | 2017 |
| (P010) Concurrent Chemotherapy With Adjuvant Radiation for Breast Cancer After Incomplete Response to Neoadjuvant Chemotherapy: Safety and Outcomes TD Mullen, AE Chang, HM Linden, JN Kim International Journal of Radiation Oncology• Biology• Physics 98 (2), E18, 2017 | | 2017 |
| RETROSPECTIVE ANALYSIS OF ADULT HEAD AND NECK SARCOMA: A SINGLE-CENTER EXPERIENCE FROM 2000-2012 A Chang, X Chai, N Futran, R Jones JOURNAL OF INVESTIGATIVE MEDICINE 61 (1), 228-228, 2013 | | 2013 |
| Modulation of pancreas cancer invasion and metastasis by SMAD4/DPC4 signaling VK Goel, PG Rani, K Izeradjene, P Calses, C Gard, PP Provenzano, ... Cancer Research 71 (8 Supplement), 1487-1487, 2011 | | 2011 |
| Treatment Failure of a TLR-7 Agonist Occurs ER Larson, A Chang, H Tufvesson, MLH Duan, LM Amon, N Van Denend, ... | | 2010 |
| Antitumor Immunity Induced by Toll-like Receptor-7 Ligation is Limited by Inflammation-induced Immunosuppression but can be Restored through Interleukin-10 Blockade H Lu, E Gad, Y Yang, A Chang, ML Disis JOURNAL OF IMMUNOTHERAPY 32 (9), 998-998, 2009 | | 2009 |
| Immunomodulation by PSK augments the anti-tumor effect of paclitaxel in mice with locally advanced breast cancers H Lu, E Gad, A Chang, ML Disis Cancer Research 68 (9 Supplement), 2083-2083, 2008 | | 2008 |
| Immunomodulatory effects of polysaccharide krestin K H Lu, CA Wenner, E Gad, Y Dang, M Martzen, E Larson, A Chang, ... JOURNAL OF IMMUNOTHERAPY 30 (8), 883-883, 2007 | | 2007 |
| Identification of an immunological signature of tumor rejection in the neu transgenic mouse H Lu, A Chang, E Larson, E Gad, M Disis Cancer Research 67 (9 Supplement), 4131-4131, 2007 | | 2007 |
